Deutsche Bank
SUPN icon

Deutsche Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

Deutsche Bank’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-455
Closed -$13K – 4257
2021
Q4 		$13K Buy
455
+224
+97% +$6.8K ﹤0.01% 4150
2021
Q3 		$6K Sell
231
-6
-3% -$161 ﹤0.01% 4327
2021
Q2 		$7K Buy
+237
New +$7.27K ﹤0.01% 4487
2020
Q4 		– Sell
-200
Closed -$4K – 4522
2020
Q3 		$4K Buy
+200
New +$4.54K ﹤0.01% 4266

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Deutsche Bank's SUPN Position: Q2 2026 in Review

Deutsche Bank reduced its Supernus Pharmaceuticals (SUPN) stake by 46% in Q2 2026, selling an estimated $2.63M and leaving 63,729 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Deutsche Bank first reported a position in SUPN in Q2 2013 and has held it in 53 quarters since. The position peaked at $48.2M in Q2 2018. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Deutsche Bank held 63,729 shares of Supernus Pharmaceuticals worth $2.96M as of Q2 2026.
  • Deutsche Bank sold 54,821 Supernus Pharmaceuticals shares in Q2 2026, an estimated $2.63M.
  • Supernus Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1682 holding.
  • Deutsche Bank first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Supernus Pharmaceuticals position peaked at $48.2M in Q2 2018.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.